- Home
- HEPA vs DATS Comparison
HEPA vs DATS Comparison
Compare HEPA & DATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEPA
- DATS
- Stock Information
- Founded
- HEPA 2013
- DATS 2014
- Country
- HEPA United States
- DATS United States
- Employees
- HEPA N/A
- DATS N/A
- Industry
- HEPA Biotechnology: Pharmaceutical Preparations
- DATS Computer Software: Prepackaged Software
- Sector
- HEPA Health Care
- DATS Technology
- Exchange
- HEPA Nasdaq
- DATS Nasdaq
- Market Cap
- HEPA 4.7M
- DATS 4.8M
- IPO Year
- HEPA N/A
- DATS 2021
- Fundamental
- Price
- HEPA $0.68
- DATS $2.26
- Analyst Decision
- HEPA Hold
- DATS
- Analyst Count
- HEPA 1
- DATS 0
- Target Price
- HEPA N/A
- DATS N/A
- AVG Volume (30 Days)
- HEPA 39.0K
- DATS 3.5M
- Earning Date
- HEPA 11-26-2024
- DATS 11-26-2024
- Dividend Yield
- HEPA N/A
- DATS N/A
- EPS Growth
- HEPA N/A
- DATS N/A
- EPS
- HEPA N/A
- DATS N/A
- Revenue
- HEPA N/A
- DATS $515.00
- Revenue This Year
- HEPA N/A
- DATS N/A
- Revenue Next Year
- HEPA N/A
- DATS N/A
- P/E Ratio
- HEPA N/A
- DATS N/A
- Revenue Growth
- HEPA N/A
- DATS N/A
- 52 Week Low
- HEPA $0.55
- DATS $1.01
- 52 Week High
- HEPA $4.47
- DATS $4.13
- Technical
- Relative Strength Index (RSI)
- HEPA 52.88
- DATS 62.96
- Support Level
- HEPA $0.60
- DATS $1.83
- Resistance Level
- HEPA $0.68
- DATS $2.54
- Average True Range (ATR)
- HEPA 0.05
- DATS 0.38
- MACD
- HEPA 0.00
- DATS 0.05
- Stochastic Oscillator
- HEPA 87.80
- DATS 39.64
About HEPA Hepion Pharmaceuticals Inc.
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts, even after they are sent.